CBIO - Catalyst Biosciences

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

CBIO - Catalyst Biosciences

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ
#6732()/6981

Fri 20'th Jul 2018

PERIOD 2018-04-23 - 2018-07-20
CHANGE -4.86%
PRICE $10.38
VOLUME
Sell
TREND
Sell

MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Buy

Request Prediction
0.00%
Predict

Catalyst Biosciences Stock Analysis

Technical stock analysis for Fri 20'th Jul 2018

Sell candidate since 2018-07-16 Loss -14.99%
Shorts 0.88% ( 2018-06-29 )
Cash 59.8 mill
Loans n/a
Beta 1.84
ROA -30.20

Catalyst Biosciences fell by -4.86% in the last day from $10.91 to $10.38 and has now fallen 6 days in a row. The price has fallen in 6 of the last 10 days and is down by -8.87% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -304 175 shares and in total 760 105 shares bought and sold for approximately $7.89 million.

Trend

Catalyst Biosciences lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -56.39% during the next 3 months and, with 90% probability hold a price between $0.43 and $7.38 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Catalyst Biosciences holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $11.69 and $15.42. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday July 13, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 31 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Catalyst Biosciences finds support from accumulated volume at $10.37.

Support: $10.37 Price: $10.38 Resistance: $10.46

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.95 between high and low, or 9.48%. For the last week, the stock has had a daily average volatility of 11.91%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation

Catalyst Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.

Strong Sell Candidate

Click for Top 5 Strong Sell Candidates
CBIO $10.38 $-0.53(-4.86%)
CBIO is down $0.53 today, but where's it headed in August?
Zacks Investment Research is releasing its prediction for CBIO based on the 1-3 month system that more than doubles the S&P 500.

Click here – the CBIO analysis is free »
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at


in partnership with
START FREE 5-DAY TRIAL